#27 - Pharmacology of drugs

A special treat this week as the two titans of psychopharmacology discuss the medicinal chemistry of psychedelics. Dr Nichols is the Founding President of the Heffter Research Institute, an organisation designed to promote research of the highest scientific quality with psychedelics in order to contribute to a greater understanding of the mind leading to the  …


Medical cannabis in the UK: From principle to practice

Authors: Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh, David J Nutt Published: June 10, 2020 Read the full paper here (open access) Drug Science submits it's finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science  …

#19 - DMT

  DMT is a drug that’s relatively novel in western neuropsychopharmacology. Not much research has been done on this substance to date and many intoxicants are unable to recount their psychedelic experience. For the first time, this substance is being studied in an fMRI and EEG to elucidate why and how this drug elucidates vivid  …


#10 - MDMA-Assisted therapy

Dr Ben Sessa was the first doctor to administer MDMA assisted therapy in the 21st century and Christopher Trudgian was one of his very first patients. They both join Professor David Nutt to answer the question… can MDMA be used therapeutically to treat addiction and/or PTSD? The links between childhood trauma/PTSD and adult addiction are very  …


#8 - Medical Cannabis, Mum and Me

Lucy Stafford is a medical cannabis patient and advocate. Having spent most of her teenage years in severe pain, dependent on opiates and a feeding tube, discovering medical cannabis has transformed her health and quality of life. She is passionate about working towards a healthcare system that integrates the use of medical cannabis in the  …


Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts

Authors: Natasha L Mason, Patrick C Dolder, Kim PC Kuypers Published: January 30, 2020 Background It has been suggested that the outcome of the psychedelic experience is dependent on set and setting. While scientific research into the therapeutic potential of psychedelics is growing, it is clear that in clinical populations an optimal set and setting  …